Clinical Trials in Boston

Showing 7641-7660 of 17,836 trials

Thiamine as a Renal Protective Agent in Septic Shock

NCT03550794

This is a randomized, double-blind, placebo controlled study to investigate the effect of intravenous thiamine (vitamin B1) on renal function in septic shock.

SepsisKidney InjuryThiamine Deficiency

Beth Israel Deaconess Medical Center95 participantsStarted Sep 2018

Boston, Massachusetts, United States • Manhasset, New York, United States • New York, New York, United States +1 more locations

COMPLETEDPhase 2< 1 mile

The TIME-2b Study: A Study of AKB-9778 (Razuprotafib), a Novel Tie 2 Activator, in Patients With Non-Proliferative Diabetic Retinopathy (NPDR)

NCT03197870

The purpose of this study is to evaluate the safety and efficacy of subcutaneously administered AKB-9778 15mg once daily or 15mg twice daily for 12 months in patients with moderate to severe non-proliferative diabetic retinopathy (NPDR).

Nonproliferative Diabetic Retinopathy

EyePoint Pharmaceuticals, Inc.167 participantsStarted Jun 2017

Phoenix, Arizona, United States • Phoenix, Arizona, United States • Arcadia, California, United States +50 more locations

Thiamine as a Renal Protective Agent in Septic Shock

The TIME-2b Study: A Study of AKB-9778 (Razuprotafib), a Novel Tie 2 Activator, in Patients With Non-Proliferative Diabetic Retinopathy (NPDR)

Find Trials by Condition in Boston

Evaluation of Patient Outcomes From the Kidney Allograft Outcomes AlloSure Registry

Dose-Esc/Exp RMC4630 & Cobi in Relapsed/Refractory Solid Tumors & RMC4630& Osi in EGFR+ Locally Adv/Meta NSCLC

Rosiglitazone in Treating Patients With Liposarcoma

Efficacy and Safety Study of BCX7353 as an Oral Treatment for the Prevention of Attacks in HAE

The Adapting Disease Specific Outcome Measures Pilot Trial for Telehealth in Myasthenia Gravis

Study to Assess the Efficacy and Safety of Umbralisib in Participants With Non-Follicular Indolent Non-Hodgkin's Lymphoma

High-Dose Melphalan Plus Peripheral Stem Cell Transplantation in Treating Patients With Primary Systemic Amyloidosis

Theophylline in Treating Patients With In Situ, Stage I, or Stage II Chronic Lymphocytic Leukemia

Combination Chemotherapy After Surgery in Treating Patients With Cancer of the Esophagus or Stomach

Study of Lenvatinib in Subjects With Advanced Endometrial Cancer and Disease Progression

Eribulin Mesylate in Combination With Intermittent Erlotinib in Patients With Previously Treated, Advanced Non-Small Cell Lung Cancer

Values-Affirmation Intervention Targeting Medication Adherence in Older Adults With Heart Failure

Clinical Performance of Senofilcon A Investigational Lens

Methotrexate Compared With Paclitaxel in Treating Patients With Advanced Head and Neck Cancer

Irinotecan Plus E7820 Versus FOLFIRI in Second-Line Therapy in Patients With Locally Advanced or Metastatic Colon or Rectal Cancer

Eribulin Mesylate Administered in Combination With Pemetrexed Versus Pemetrexed Alone as Second Line Therapy in Patients With Stage IIIB or IV Nonsquamous Non Small Cell Lung Cancer

Study of Adjunctive Ganaxolone Treatment in Female Children With Protocadherin 19 (PCDH19)-Related Epilepsy (Violet Study)

A Study of the Burden of Illness and Treatment Patterns in Teenagers and Adults With Hereditary Angioedema